Riskpilot← Back to searchSign inGet full accessDocFab AB
ABActiveOrg 5591950000Insjövägen 4 AMedical specialists activities · NACE 8622Est. 20191 employees
Revenue 2024
SEK 3,4M
+6% vs 2023
EBITDA margin
56.9%
+15% vs 2023
Equity ratio
56.6%
Financial strength
Net profit 2024
SEK 1,1M
+8% vs 2023
| Revenue | SEK 3,4M | +6% |
| EBITDA | SEK 2M | +15% |
| Net profit | SEK 1,1M | +8% |
| Total assets | SEK 8M | +21% |
| Equity | SEK 4,5M | +25% |
| Employees | 1 | — |
Legal name
DocFab AB
Org number
5591950000
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
14 februari 2019
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Medicinsk konsultverksamhet. Läkarvård och medicinska tjänster. Föreläsningar och undervisning inom medicin.
Address
Insjövägen 4 A
Email
ann.abrahamsson@yahoo.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | — | 2 656 | 2 871 | 3 232 | 3 438 |
| Staff expenses | — | — | −806 | −1 050 | −1 039 |
| EBITDA | 0 | 1 558 | 1 726 | 1 699 | 1 955 |
| Depreciation & amort. | — | −0 | — | — | −76 |
| EBIT | 0 | 1 558 | 1 726 | 1 699 | 1 879 |
| Net financials | — | −2 | −2 | 70 | 58 |
| Profit before tax | 0 | 1 167 | 1 293 | 1 319 | 1 437 |
| Tax | — | −244 | −274 | −286 | −320 |
| Net profit | — | 923 | 1 019 | 1 034 | 1 117 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | — | 4 178 | 5 404 | 6 614 | 7 986 |
| Equity | — | 1 938 | 2 771 | 3 609 | 4 523 |
| Long-term debt | — | 0 | — | — | — |
| Short-term debt | — | 1 285 | 1 248 | 1 169 | 1 129 |
| Total debt | — | 1 285 | 1 248 | 1 169 | 1 129 |
EBITDA margin
56.9%
This company
15.8%
Market median
+260% vs market
20202024
Equity ratio
56.6%
This company
38.2%
Market median
+48% vs market
20202024
Return on equity
24.7%
This company
18.4%
Market median
+34% vs market
20202024
Net profit margin
32.5%
This company
8.1%
Market median
+301% vs market
20202024
Asset turnover
0.43×
This company
1.12×
Market median
-62% vs market
20202024
Debt / equity
0.77×
This company
0.62×
Market median
+24% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
PB Chief Executive Officer | Chief Executive Officer | 2022 |
AH Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2025 | |
| Deputy Board Member | 2020 | |
| Former (1) | ||
| Chairman | 2021 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DocFab AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Bo Carl Abrahamsson | Chief Executive Officer | 0 companies |
| Ann Helena Abrahamsson | Chief Executive Officer | 0 companies |
| Beata Anna Maria Abrahamsson | Deputy Board Member | 0 companies |
| Ebba Elisabet Abrahamsson | Deputy Board Member | 0 companies |
| Lina Birgitta Josefin Abrahamsson | Chairman | 0 companies |